ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,906.94
-1.07%
Dow Jones
42,573.73
-0.97%
US Dollar vs MXN
20.66281
0.08%
Brent Oil
74.435
0.45%
Bitcoin
92,121.54
-0.58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Avenue Therapeutics Inc (ATXI) Cotización

Avenue Therapeutics Inc

Avenue Therapeutics Inc (ATXI)

NASDAQ
1.94
0.00
(0.00%)
Cerrado 30 Diciembre 3:00PM
Delayed by 15 minutes
1.92
-0.02
(-1.03%)
Fuera de horario: 4:33PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.92
Postura de Compra
1.85
Postura de Venta
1.92
Volume Operado de la Acción
43,791
1.80 Rango del Día 1.98
1.60 Rango de 52 semanas 26.4675
Capitalización de Mercado [m]
3.67M
Precio Anterior
1.94
Precio de Apertura
1.94
Hora
3
@
1.9
Última hora de negociación
Volumen financiero
US$ 82,703
Precio Promedio Ponderado
1.8886
Volumen promedio (3 m)
48,301
Acciones en circulación
1,911,633
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.36
Beneficio por acción (BPA)
-5.43
turnover
-
Beneficio neto
-10.38M

Acerca de Avenue Therapeutics Inc

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.avenuetx.com
Sede
Dover, Delaware, USA
Fundado
-
Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXI. The last closing price for Avenue Therapeutics was US$1.94. Over the last year, Avenue Therapeutics shares have traded in a share price range of US$ 1.60 to US$ 26.4675.

Avenue Therapeutics currently has 1,911,633 shares in issue. The market capitalisation of Avenue Therapeutics is US$3.71 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.36.

ATXI Últimas noticias

Más noticias

Form S-3 - Registration statement under Securities Act of 1933

04 Diciembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

29 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Noviembre 2024
Edgar (US Regulatory)

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

14 Noviembre 2024
GlobeNewswire Inc.

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

09 Octubre 2024
GlobeNewswire Inc.

Form 8-K - Current report

27 Septiembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Septiembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Septiembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Septiembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.126.666666666671.81.991.64315711.83790611CS
40.084.347826086961.8421.63305471.83929875CS
12-0.18-8.571428571432.12.71.6483012.064879CS
26-1.65-46.2184873953.573.93131.6461812.50136532CS
52-10.5825-84.643071385712.502526.46751.6150405718.3247609CS
156-995.955-99.8075911312997.8751406.251.61764048315.62746873CS
260-10404.33-99.981549549510406.25141301.61148493702.26406672CS

ATXI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Avenue Therapeutics?
El precio actual de las acciones de Avenue Therapeutics es US$ 1.92
¿Cuántas acciones de Avenue Therapeutics están en circulación?
Avenue Therapeutics tiene 1,911,633 acciones en circulación
¿Cuál es la capitalización de mercado de Avenue Therapeutics?
La capitalización de mercado de Avenue Therapeutics es USD 3.71M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Avenue Therapeutics?
Avenue Therapeutics ha negociado en un rango de US$ 1.60 a US$ 26.4675 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Avenue Therapeutics?
El ratio precio/beneficio de Avenue Therapeutics es -0.36
¿Cuál es la moneda de reporte de Avenue Therapeutics?
Avenue Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Avenue Therapeutics?
El último beneficio anual de Avenue Therapeutics es USD -10.38M
¿Cuál es la dirección registrada de Avenue Therapeutics?
La dirección registrada de Avenue Therapeutics es 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
¿Cuál es la dirección del sitio web de Avenue Therapeutics?
La dirección del sitio web de Avenue Therapeutics es www.avenuetx.com
¿En qué sector industrial opera Avenue Therapeutics?
Avenue Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WATTEnergous Corporation
US$ 2.70
(556.61%)
225.47M
NXUNXU Inc
US$ 1.52
(524.49%)
569.35M
HOLOMicroCloud Hologram Inc
US$ 6.40
(166.67%)
219.75M
INTZIntrusion Inc
US$ 5.67
(162.50%)
131.47M
SMXSMX Security Matters Public Company
US$ 0.803558
(127.25%)
370.01M
ICGIntchains Group Ltd
US$ 3.39
(-63.67%)
1.76M
ABPAbpro Holdings Inc
US$ 2.10
(-53.23%)
2.17M
LITMSnow Lake Resources Ltd
US$ 0.9212
(-42.43%)
68.48M
TRAWTraws Pharma Inc
US$ 8.33
(-37.93%)
1.18M
BDMDBaird Medical Investment Holdings Ltd
US$ 1.07
(-37.79%)
152.51k
NXUNXU Inc
US$ 1.52
(524.49%)
572.73M
SMXSMX Security Matters Public Company
US$ 0.803558
(127.25%)
370.63M
VINCVincerx Inc
US$ 0.3243
(67.16%)
335.59M
XTIAXTI Aerospace Inc
US$ 0.0395
(0.00%)
292.67M
WATTEnergous Corporation
US$ 2.70
(556.61%)
226.21M

ATXI Discussion

Ver más
tw0122 tw0122 2 meses hace
ATXI 2.40 + 18% up to 2.80s earlier higher risk about 1m float
2.24-2.34 need support to hold and some follow through
2.51- 3.02 profit zone 1
3.38- 3.81 profit zone 2
👍️0
Monksdream Monksdream 5 meses hace
ATXI new 52 week low
👍️0
Disquisition Disquisition 8 meses hace
INCOMPREHENSIBLE DUMPING
👍️0
jelaco jelaco 10 meses hace
When is the Nas min compliance hearing.. anyone hear anything on that? Also, when's the r/s coming?
👍️0
Animas Animas 11 meses hace
yea I flipped twice and loss twice.
👍️0
DeafTrader2 DeafTrader2 11 meses hace
I flipped it . No longer holding this ticker .
👍️0
Animas Animas 11 meses hace
Notice of Effectiveness: New Five Year Low .113
R/S Coming Soon, to Stay Alive.
👍️0
heyitsmeagain heyitsmeagain 11 meses hace
Money
👍️0
81vette 81vette 11 meses hace
Todays email to me from ATXI,approved increase of outstanding to 200m(from 75m) also warrants issued .30(also reduced previous to exercise at .30)reason was they only had 161k cash left(ran out of $) debt is now $191m
👍️0
glenn1919 glenn1919 11 meses hace
ATXI..............................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783
👍️0
DeafTrader2 DeafTrader2 11 meses hace
Chart is improving ... Have bottomed out ..

YUUUPPPP
👍️0
DeafTrader2 DeafTrader2 11 meses hace
Wow ! ... What Happened Back Then ? Curious
👍️0
DeafTrader2 DeafTrader2 11 meses hace
IV Tramadol itself is a huge profit but are there other competitors that sell this drug ?
👍️0
DeafTrader2 DeafTrader2 11 meses hace
Is this stock a good buy right now ? 200M o/s
👍️0
81vette 81vette 11 meses hace
Filing states,approved raising o/s to 200M from 75M
👍️0
81vette 81vette 11 meses hace
I lost on first try to play,waiting for a bullish sign to try again (maybe,lose more) volume fading out is bad also
👍️0
81vette 81vette 11 meses hace
Buyout is best for shareholders short term with a big run and done
👍️ 1 💯 1 ☝️ 1
DeafTrader2 DeafTrader2 11 meses hace
Is buy out a good thing for this ticker ?
👍️0
DeafTrader2 DeafTrader2 12 meses hace
Bottomed Out ... Shoulda, coulda, woulda ..... ?
👍️0
RAlbert RAlbert 12 meses hace
Why so? What am I missing here?
👍️0
DeafTrader2 DeafTrader2 12 meses hace
Pendant northward ... sqeeze as FK
👍️0
DeafTrader2 DeafTrader2 12 meses hace
I am pissed that I FLIPPED THIS Today .l.. STUPID
👍️0
81vette 81vette 12 meses hace
Money raise warrants,ends tomorrow,ppl loading up,accumulation continues
🏁 1 👍️ 1 💯 1 ☝️ 1
DeafTrader2 DeafTrader2 12 meses hace
this plane crashing back to this level ...
👍️0
TheFinalCD TheFinalCD 12 meses hace
atxi .18's

get em while they're hot

LOL
👍️0
Sunset Kid Sunset Kid 12 meses hace
Current O/S is 30M per dilution tracker. 90% were sold to investors in Nov and Jan. @ .30/share. Those transactions have provided $10M to the company for 2024 operating budget. https://dilutiontracker.com/app/search/ATXI
👍️0
Sunset Kid Sunset Kid 12 meses hace
They sold 16.5 million shares (warrants) @ .30 for $5M. Funding for 2024 in place with less than 20M outstanding. This surge means something good is coming, imo. This is on everyones radar now. Let's squeeze the shorts to over a buck this week.
👍️0
Sunset Kid Sunset Kid 12 meses hace
ATXI is #1 weekly and monthly gainer under a buck. Float has traded multipble times last week. Lets rock their world.
👍️0
glenn1919 glenn1919 12 meses hace
ATXI...........................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783
👍️0
Sauerkraut Sauerkraut 12 meses hace
Yes. Worked out well. Now sell @.30 and stopp @.15.
Glty
👍️0
TheFinalCD TheFinalCD 12 meses hace
correction .1981 avg

im tired

good weekend all
👍️0
TheFinalCD TheFinalCD 12 meses hace
good call I had 20k bid @ .1625 it stops .1632 :/

MFalgoz

I bought 10k @ .2216 & 10K .175

holding 20k avg .2081

wonder if it tests .15 again?

may wait to see before I add more


38 to 18 what a shitshow
👍️0
RAlbert RAlbert 12 meses hace
The warrants exercising at little over 30 cents is a good sign when compared with current share price. It is a steal to buy in at .185
👍️0
DeafTrader2 DeafTrader2 12 meses hace
Will add position Monday and Tuesday
👍️0
81vette 81vette 12 meses hace
Tripled my position with .185s,run started 17ish yesterday
👍️ 1 💯 1 ☝️ 1
DeafTrader2 DeafTrader2 12 meses hace
Its a F.U. message from CEO ... !!!
👍️0
DeafTrader2 DeafTrader2 12 meses hace
Avenue Therapeutics Shares Drop 42% After Warrants Exercised
👍️0
81vette 81vette 12 meses hace
Ppl saying dilution,it’s warrants 20-50k orders,could run out (15m issued) before 9th (I wanted to say soon,but that’s just the greed/devil on my shoulder lol)
👍️0
81vette 81vette 12 meses hace
Pr states “could be strategic partnership” bring on a big name pharma and that 1.55 will be pffft (could be why only raising 5m,make partner pay the 50m for study and phase 4-5 to market,or sell it for 300m,lots of speculation on many ppls minds,confidence to me would be insider’s buying,that might create big run up to the 1.55
👍️0
trendzone trendzone 12 meses hace
Not in the stock price,but if someone keeps averaging down from much higher levels too many times,and the stock keeps tanking, they could find themselves in a situation of being down that much on the amount of money they originally invested.
👍️0
TheFinalCD TheFinalCD 12 meses hace
at least we are doing better than IVP

what a falling knife that was
👍️0
81vette 81vette 12 meses hace
$1.55 issued exercise,reduced price is .3006,closing on 9th
👍️0
TheFinalCD TheFinalCD 12 meses hace
VWAP .2317


todays news didnt help https://www.globenewswire.com/news-release/2024/01/05/2804696/0/en/Avenue-Therapeutics-Enters-into-Warrant-Exercise-Transactions-for-5-0-Million-in-Proceeds.html
👍️0
Triple nickle Triple nickle 12 meses hace
Yup in it avg’ing down thought it would go .18 but not happening
👍️0
Sauerkraut Sauerkraut 12 meses hace
Bid @.17
👍️0
TheFinalCD TheFinalCD 12 meses hace
how is anything down more than -100%

please tell us LL

Message in reply to:
If you were compared to a stock, you would be considered a toxic diluted OTC that's down over 300% from its highs.
👍️0
Sauerkraut Sauerkraut 12 meses hace
Closing the Gap
👍️0
TheFinalCD TheFinalCD 12 meses hace
where you at with atxi

you still in, cut bait, coming back??

trickle nickle @ .48 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173562791

Message in reply to:
I tap it to keep it moving but to answer your question worst .28 I don’t think we’re done just yet this is the first day of three
👍️0
TheFinalCD TheFinalCD 12 meses hace
sure just do the same when you see me on a board but not posting


Message in reply to:
I missed it,was busy with other things,thanks for the heads up,appreciated !!
👍️0
TheFinalCD TheFinalCD 12 meses hace
filled more .21's will it hold???
👍️0

Su Consulta Reciente

NASDAQ
ATXI
Avenue Therapeutics
BIT
XCS2
Australia SSA Bonds UCIT...
AMEX
DMF
BNY Mellon Municipal Inc...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados